机译:预测可能无法受益于细胞射孔的转移性肾细胞癌患者的临床变量:中性粒细胞到淋巴细胞比率和性能状态
Department of Urology Tokyo Medical University 6-7-1 Nishishinjuku Shinjuku-ku Tokyo 1600023;
Department of Urology Tokyo Medical University 6-7-1 Nishishinjuku Shinjuku-ku Tokyo 1600023;
Department of Urology Tokyo Medical University 6-7-1 Nishishinjuku Shinjuku-ku Tokyo 1600023;
Department of Urology Tokyo Medical University 6-7-1 Nishishinjuku Shinjuku-ku Tokyo 1600023;
Department of Urology Tokyo Medical University 6-7-1 Nishishinjuku Shinjuku-ku Tokyo 1600023;
Department of Urology Tokyo Medical University 6-7-1 Nishishinjuku Shinjuku-ku Tokyo 1600023;
Department of Urology Tokyo Medical University 6-7-1 Nishishinjuku Shinjuku-ku Tokyo 1600023;
Department of Urology Tokyo Medical University 6-7-1 Nishishinjuku Shinjuku-ku Tokyo 1600023;
Cytoreductive nephrectomy; Metastases; Neutrophil-to-lymphocyte ratio; Prediction model; Renal cell carcinoma;
机译:预测可能无法从减细胞肾切除术中受益的转移性肾细胞癌患者的临床变量:中性粒细胞与淋巴细胞的比例和表现状态
机译:转移性肾细胞癌患者受益于细胞减少性肾切除术和中性白细胞与淋巴细胞比的预后作用
机译:转移性透明细胞肾细胞癌行细胞还原性肾切除术的患者术前中性粒细胞与淋巴细胞比例升高可能与总生存期降低有关
机译:何时治疗转移性肾细胞癌的组合,全身治疗,以及在转移性肾癌中的活跃监测
机译:用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
机译:转移性透明细胞肾细胞癌行细胞减灭性肾切除术的患者术前中性粒细胞与淋巴细胞比例升高可能与总生存期降低有关
机译:术前中性粒细胞与淋巴细胞比率升高可能与接受细胞减灭性肾切除术的转移性透明细胞肾细胞癌患者的总体生存率降低有关